Evidence map›Paper›PMID 31004190›Full record

ArticleLung2019

Adherence to Long-Term Follow-Up of Patients with Life-Threatening, Inhaled Synthetic Cannabinoids-Associated Coagulopathy in Chicago.

Mateo Tole, Stephanie LaBedz, Douglas L Feinstein, Israel Rubinstein

Abstract read
In one paragraph

Article in Lung, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Non-adherence with long-term oral vitamin KToxicology communications · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mateo ToleDivision of Pulmonary, Critical Care, Sleep and Allergy Medicine, Department of Medicine (M/C 719), University of Illinois at Chicago, 840 South Wood Street, Chicago, IL, 60612, USA.
Stephanie LaBedzDivision of Pulmonary, Critical Care, Sleep and Allergy Medicine, Department of Medicine (M/C 719), University of Illinois at Chicago, 840 South Wood Street, Chicago, IL, 60612, USA.
Douglas L FeinsteinDepartment of Anesthesiology, University of Illinois at Chicago, Chicago, IL, 60612, USA.
Israel RubinsteinDivision of Pulmonary, Critical Care, Sleep and Allergy Medicine, Department of Medicine (M/C 719), University of Illinois at Chicago, 840 South Wood Street, Chicago, IL, 60612, USA. irubinst@uic.edu.

Funding

Intralipid: A novel frontline countermeasure for brodifacoum poisoningU01NS083457 · NINDS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI FEINSTEIN, DOUGLAS L. · 2013 to 2018
$3.6M
41st Annual Meeting of American Society for NeurochemistryR13NS070510 · NINDS · AMERICAN SOCIETY FOR NEUROCHEMISTRY · PI FEINSTEIN, DOUGLAS L. · 2010 to 2010
$18k
BLRD VA IK6 BX004852NINDS NIH HHS R13 NS070510NINDS NIH HHS U01 NS083457
6 · The paper itself

Abstract

A large-scale outbreak of life-threatening, inhaled synthetic cannabinoids (Spice/K2)-associated coagulopathy with bleeding complications was recently reported in Illinois. The causative agents were brodifacoum, difenacoum, and bromadiolone, potent, long-acting, 4-hydroxycoumarin anticoagulant rodenticides (LAAR) that were mixed with Spice/K2 products procured and then inhaled by the victims. We report on 3 poisoned patients who reside in underserved, socioeconomically disadvantaged neighborhoods of Chicago that were admitted and treated successfully at two inner-city, tertiary care hospitals in Chicago. The patients were discharged from the hospitals on daily long-term high-dose oral vitamin K

Indexed as

CannabinoidsPatient Compliance4-HydroxycoumarinsAdministration, InhalationAdultAftercareAnticoagulantsAntifibrinolytic AgentsBlood Coagulation DisordersChicagoFemaleHemorrhageHumansInternational Normalized RatioLost to Follow-UpMale4-HydroxycoumarinsAnticoagulantsAntifibrinolytic AgentsbromadiolonebromfenacoumCannabinoidsdifenacoumSynthetic DrugsVitamin K 1BrodifacoumBromadioloneDifenacoumRodenticideSuperwarfarinsVitamin K

Identifiers

PMID31004190
PMCPMC6522275

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.